One recently published study found no mortality benefit to annual screening mammograms, but critics cry "foul."
HER2 screening and emetine dihydrochloride may offer patients with bladder cancer more effective treatment options.
The journal Science named cancer immunotherapy as "the breakthrough of the year"; but challenges still remain to overcome tumor immune suppression and genomic instability.
Although imatinib is the current standard of care for gastrointestinal stromal tumors, other therapies are proving to be effective treatments for the disease as well.
The time-to-market for cancer drugs can often prevent patients from getting desperately needed treatment; patients and manufacturers are looking to change this fact.
E-cigarettes have gained popularity over the last few years, but are they really as safe as people may think?
Autophagy inhibition may prove to be a valuable tool for overcoming TKI resistance when treating chronic myeloid leukemia.
As the Baby Boomer generation ages, more than ever there is a need for improved cancer care for the elderly patients.
Understanding the mechanisms of resistance to TKIs is crucial when approaching and managing the problem.
Increased use of EHRs and other technology may mean less in-person visits and more "virtual" interactions between doctor and patient.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|